Patents by Inventor Moses Folkman

Moses Folkman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Estrogenic compounds as anti-mitotic agents
    Publication number: 20060183727
    Abstract: The application discloses methods of treating mammalian diseases characterized by abnormal cell mitosis by administering estradiol derivatives including those comprising colchicine or combretastatin A-4 structural motifs of the general formulae found below in a dosage sufficient to inhibit cell mitosis. The application discloses novel compounds used in the methods.
    Type: Application
    Filed: April 12, 2006
    Publication date: August 17, 2006
    Inventors: Robert D'Amato, Moses Folkman
  • Estrogenic compounds as anti-mitotic agents
    Publication number: 20060079576
    Abstract: The application discloses methods of treating mammalian diseases characterized by abnormal cell mitosis by administering estradiol derivatives including those comprising colchicine or combretastatin A-4 structural motifs of the general formulae found below in a dosage sufficient to inhibit cell mitosis. The application discloses novel compounds used in the methods.
    Type: Application
    Filed: May 19, 2005
    Publication date: April 13, 2006
    Inventors: Robert D'Amato, Moses Folkman
  • Estrogenic compounds as anti-mitotic agents
    Publication number: 20050020555
    Abstract: The application discloses methods of treating mammalian diseases characterized by abnormal cell mitosis by administering estradiol derivatives including those comprising colchicine or combretastatin A-4 structural motifs of the general formulae found below in a dosage sufficient to inhibit cell mitosis. The application discloses novel compounds used in the methods.
    Type: Application
    Filed: August 12, 2004
    Publication date: January 27, 2005
    Inventors: Robert D'Amato, Moses Folkman